Evaluation of the Cryocheck HexLA Integrated TCA for the Detection of Lupus Anticoagulant

Recruiting Observational Study
Lupus Anticoagulant
No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
200 (estimated)
Sponsor
University Hospital, Strasbourg, France · Other
Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial
Lupus anticoagulant (LA) testing is performed using two screening tests: activated partial thromboplastin time (APTT) and diluted Russell's viper venom time. If one of the screening tests is positive, a confirmation test based on the same principle is performed. The HUS Hematology Laboratory uses an integrated APTT for LA testing, consisting of a screening reagent: Cephen LS, and a confirmation r…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Patient of legal age (≥ 18 years) * Sample sent to the HUS Hematology Laboratory and analyzed for LA detection as part of routine care. Exclusion Criteria: \- Insufficient sample volume
Contacts

Agathe HERB, PharmD

33 3 88 12 75 53

agathe.herb@chru-strasbourg.fr

CONTACT